Predispositional genome sequencing in healthy adults: design, participant characteristics, and early outcomes of the PeopleSeq Consortium

[1]  R. Green,et al.  The BabySeq project: implementing genomic sequencing in newborns , 2018, BMC Pediatrics.

[2]  James M Ford,et al.  Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk , 2017, Genetics in Medicine.

[3]  Anders M. Dale,et al.  Precision medicine screening using whole-genome sequencing and advanced imaging to identify disease risk in adults , 2017, Proceedings of the National Academy of Sciences.

[4]  S. Ghorbian,et al.  Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis , 2017, Pathology & Oncology Research.

[5]  H. Rehm.  Evolving health care through personal genomics , 2017, Nature Reviews Genetics.

[6]  Robert C. Green,et al.  Direct-to-Consumer Genetic Testing: User Motivations, Decision Making, and Perceived Utility of Results , 2017, Public Health Genomics.

[7]  A. Kasarskis,et al.  Psychological and behavioural impact of returning personal results from whole-genome sequencing: the HealthSeq project , 2017, European Journal of Human Genetics.

[8]  Marylyn D. Ritchie,et al.  Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study , 2016, Science.

[9]  Marylyn D. Ritchie,et al.  Genetic identification of familial hypercholesterolemia within a single U.S. health care system , 2016, Science.

[10]  D. Nickerson,et al.  Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing , 2016, Contemporary clinical trials.

[11]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.

[12]  Stephanie Devaney,et al.  A Survey of U.S Adults’ Opinions about Conduct of a Nationwide Precision Medicine Initiative® Cohort Study of Genes and Environment , 2016, PloS one.

[13]  Peter Szolovits,et al.  Genetic Misdiagnoses and the Potential for Health Disparities. , 2016, The New England journal of medicine.

[14]  J. Roberts,et al.  Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing. , 2016, Annals of internal medicine.

[15]  R. Green,et al.  Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium , 2016, Journal of personalized medicine.

[16]  R. Green,et al.  Participants and Study Decliners’ Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing , 2016, Journal of empirical research on human research ethics : JERHRE.

[17]  Denise L. Perry,et al.  Are physicians prepared for whole genome sequencing? a qualitative analysis , 2016, Clinical genetics.

[18]  N. Powe,et al.  Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled , 2015, bioRxiv.

[19]  R. Green,et al.  Assessing the Costs and Cost-Effectiveness of Genomic Sequencing , 2015, Journal of personalized medicine.

[20]  D. Ledbetter,et al.  The Geisinger MyCode Community Health Initiative: an electronic health record-linked biobank for Precision Medicine research , 2015, Genetics in Medicine.

[21]  Jennifer B. McCormick,et al.  Whole-Exome Sequencing of 10 Scientists: Evaluation of the Process and Outcomes. , 2015, Mayo Clinic proceedings.

[22]  G. Henderson,et al.  The Promise and Peril of Genomic Screening in the General Population , 2015, Genetics in Medicine.

[23]  W. Klein,et al.  Characterizing Participants in the ClinSeq Genome Sequencing Cohort as Early Adopters of a New Health Technology , 2015, PloS one.

[24]  Larry N. Singh,et al.  Individualized iterative phenotyping for genome-wide analysis of loss-of-function mutations. , 2015, American journal of human genetics.

[25]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[26]  Robert C Green,et al.  GINA, genetic discrimination, and genomic medicine. , 2015, The New England journal of medicine.

[27]  Mick P Couper,et al.  Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers , 2014, Genome Medicine.

[28]  B. Tarini,et al.  Primary-care providers’ perceived barriers to integration of genetics services: a systematic review of the literature , 2014, Genetics in Medicine.

[29]  Leslie G Biesecker,et al.  Diagnostic clinical genome and exome sequencing. , 2014, The New England journal of medicine.

[30]  Wanda Pratt,et al.  Understanding quantified-selfers' practices in collecting and exploring personal data , 2014, CHI.

[31]  Isaac S Kohane,et al.  The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine , 2014, Trials.

[32]  K. Norris,et al.  A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. , 2014, American journal of public health.

[33]  N. Schork,et al.  Characteristics of Genomic Test Consumers Who Spontaneously Share Results With Their Health Care Provider , 2014, Health communication.

[34]  M. Gonzalez-Garay,et al.  Personalized genomic disease risk of volunteers , 2013, Proceedings of the National Academy of Sciences.

[35]  Fiona A Miller,et al.  Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care , 2013, European Journal of Human Genetics.

[36]  C. Tyler-Smith,et al.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease , 2013, Human Genetics.

[37]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[38]  Andy Anderson,et al.  Physicians' preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system. , 2013, Genetic testing and molecular biomarkers.

[39]  Haley R. Eidem,et al.  Effects of informed consent for individual genome sequencing on relevant knowledge , 2012, Clinical genetics.

[40]  C. Rotimi.  Health disparities in the genomic era: the case for diversifying ethnic representation , 2012, Genome Medicine.

[41]  C. McBride,et al.  Patients’ understanding of and responses to multiplex genetic susceptibility test results , 2012, Genetics in Medicine.

[42]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[43]  Joan Scott,et al.  Risky Business: Risk Perception and the Use of Medical Services among Customers of DTC Personal Genetic Testing , 2012, Journal of Genetic Counseling.

[44]  Eric J Topol,et al.  Consumer perceptions of direct-to-consumer personalized genomic risk assessments , 2010, Genetics in Medicine.

[45]  Misha Angrist,et al.  Personal genomes in progress: from the Human Genome Project to the Personal Genome Project , 2010, Dialogues in clinical neuroscience.

[46]  Zheng Yan,et al.  Factors affecting response rates of the web survey: A systematic review , 2010, Comput. Hum. Behav..

[47]  Alexander F. Wilson,et al.  Research in Genomic Medicine the Clinseq Project: Piloting Large-scale Genome Sequencing for Material Supplemental , 2009 .

[48]  Tao Wang,et al.  Social Networkers' Attitudes Toward Direct-to-Consumer Personal Genome Testing , 2009, The American journal of bioethics : AJOB.

[49]  Patrick Monahan,et al.  Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection , 2007, Annals of Internal Medicine.

[50]  M. Siadaty,et al.  Uptake Rates for Breast Cancer Genetic Testing: A Systematic Review , 2006, Cancer Epidemiology Biomarkers & Prevention.

[51]  B. Löwe,et al.  Detecting and monitoring depression with a two-item questionnaire (PHQ-2). , 2005, Journal of psychosomatic research.

[52]  Deb Feldman-Stewart,et al.  Validation of a Decision Regret Scale , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

[53]  M. Khoury,et al.  Population screening in the age of genomic medicine. , 2003, The New England journal of medicine.

[54]  E. Rogers,et al.  Diffusion of Innovations , 1964 .

[55]  Matthew S. Lebo,et al.  The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. , 2017, Annals of internal medicine.

[56]  Robert C. Green,et al.  Clinical Genome Sequencing , 2013 .

[57]  Avner Schlessinger,et al.  ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI , 2012 .

[58]  R. Carleton,et al.  Fearing the unknown: a short version of the Intolerance of Uncertainty Scale. , 2007, Journal of anxiety disorders.